ION717
/ Ionis
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
September 26, 2025
Therapeutic Trajectories in Human Prion Diseases.
(PubMed, Subcell Biochem)
- "The chapter also highlights the progress in clinical trials, such as the PrProfile trial for ION717, which tests a novel treatment based on an antisense oligonucleotide (ASO). As we look toward the future, the chapter underscores the need for a multifaceted approach to treating prion diseases. Furthermore, early detection methods, innovative drug delivery systems, and collaborative interdisciplinary research efforts will be essential for translating scientific discoveries into practical clinical breakthroughs."
IO biomarker • Journal • Review • CNS Disorders • PRNP
December 27, 2024
PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717
(clinicaltrials.gov)
- P1/2 | N=56 | Active, not recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Trial primary completion date: Mar 2025 ➔ Jul 2025 | Recruiting ➔ Active, not recruiting
Enrollment closed • Trial primary completion date • CNS Disorders
September 04, 2024
PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717.
(clinicaltrials.gov)
- P1/2 | N=56 | Recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Trial completion date: Oct 2025 ➔ Jun 2027
Trial completion date • CNS Disorders
August 19, 2024
PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717.
(clinicaltrials.gov)
- P1/2 | N=56 | Recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Active, not recruiting ➔ Recruiting
Enrollment open • CNS Disorders
April 09, 2024
PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717.
(clinicaltrials.gov)
- P1/2 | N=56 | Active, not recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • CNS Disorders
December 21, 2023
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717.
(clinicaltrials.gov)
- P1/2 | N=56 | Recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders
1 to 6
Of
6
Go to page
1